Sign in
Taking people in United StatesPhase 1

Stem cell exosomes tested for trigeminal neuralgia, a facial nerve pain condition

Tests exosomes from donated umbilical cord or placenta stem cells in trigeminal neuralgia.

Key facts

Who runs it
The Foundation for Orthopaedics and Regenerative Medicine
Where
Naples, United StatesSee the siteAlso in 1 other country, 1 site
Trial code
Registry title
Safety of Cultured Allogeneic Adult Umbilical Cordor Placental Derived Stem Cells Exosomes for Trigeminal Neuralgia
Status
Recruiting
Phase
Phase 1
People taking part
20 people, planned
Started
9 Sept 2022
Expected to end
Jan 2028
Type of study
Interventional
Treatments tested
  • cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cell exosomes
Record updated
20 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with trigeminal neuralgia (sudden, severe face pain from a nerve) or peripheral neuropathy (nerve damage in the limbs). It tests the safety of stem cell exosomes given through the nose.

Sex
All sexes can join.
Disease stage
A diagnosis of trigeminal neuralgia or peripheral neuropathy.
Earlier treatment
People who have had an organ transplant before cannot join.

Main reasons for not taking part

  • Active infection or active cancer
  • Long-lasting failure of several organs
  • Pregnancy, or women before menopause not using birth control
  • Ongoing drug abuse
  • Allergy to sulfur

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Diagnosis of Trigeminal Neuralgia or Peripheral Neuropathy
  • Understanding and willingness to sign a written informed consent document

Who cannot take part

  • Continued drug abuse
  • Previous organ transplant
  • Active infection
  • Active cancer
  • Chronic multisystem organ failure
  • Medical condition that would (based on the opinion of the investigator) compromise patient's safety
  • Hypersensitivity to sulfur
  • Clinically significant Abnormalities on pre-treatment laboratory evaluation
  • Pregnancy
  • Pre-menopausal women not using contraception

Where in United States

Also in 1 other country, 1 site

  • Prodromos Stem Cell InstituteNaples, United StatesContact: Chadwick Prodromos, MDTaking people

About the trial

What the trial wants to find out

This trial will study the safety and efficacy of instillation of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cell exosomes for the treatment of Trigeminal Neuralgia.

The group in the trial

  • Treatment GroupTreatment being tested

    Intranasal installation of exosomes

    Treatment: cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cell exosomes

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells Exosomes for the Treatment of Trigeminal Neuralgia
Plain-language title
Stem cell exosomes tested for trigeminal neuralgia, a facial nerve pain conditionGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
20 October 2026